Managed Account Advisors’s TherapeuticsMD TXMD Stock Holding History

Managed Account Advisors’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$18K	Buy	47 +1	+2%	+$353	﹤0.01%	2815
2015 Q1	$14K	Buy	+46	New	+$11.2K	﹤0.01%	2794
2014 Q3	–	Sell	-89	Closed	-$20K	–	2724
2014 Q2	$20K	Sell	89 -1	-1%	-$223	﹤0.01%	2508
2014 Q1	$28K	Buy	+90	New	+$28.7K	﹤0.01%	2433

Other funds holding TXMD

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Managed Account Advisors's TXMD Position: Q2 2015 in Review

Managed Account Advisors increased its TherapeuticsMD (TXMD) stake by 2.2% in Q2 2015, buying an estimated $353 and bringing the position to 47 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #2815.

Managed Account Advisors first reported a position in TXMD in Q1 2014 and has held it in 4 quarters since. The position peaked at $28K in Q1 2014. 115 funds tracked by Wall St. Rank hold TXMD as of Q2 2015.

Managed Account Advisors held 47 shares of TherapeuticsMD worth $18K as of Q2 2015.
Managed Account Advisors bought 1 TherapeuticsMD share in Q2 2015, an estimated $353.
TherapeuticsMD made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2815 holding.
Managed Account Advisors first reported a position in TherapeuticsMD in Q1 2014 and has held it in 4 quarters since.
Managed Account Advisors's TherapeuticsMD position peaked at $28K in Q1 2014.
115 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.